Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Tempus AI Study Highlights Benefits of Dual RNA and DNA Sequencing for Advanced Lung Cancer

Ontada and Datavant Partner to Expand Access to Real-World Oncology Data for Accelerated Cancer Innovation

Tempus AI and Flatiron Health Partner to Integrate Genomic Testing into OncoEMR for Enhanced Oncology Care

Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

Home
/
insight
/
details

Precision Diagnostics: Revolutionizing Bacteremia Detection with dPCR and U-HRM

NextEdge Admin

19 Apr 2024

3 min 28 sec

Digital PCR (dPCR) and Universal High-Resolution Melt (U-HRM) are advanced techniques in molecular diagnostics, specifically designed to address the limitations of traditional methods like quantitative PCR (qPCR) in the context of disease detection, with a particular focus on bacteremia.

Digital PCR is a groundbreaking technology that surpasses the limitations of qPCR in terms of accuracy and sensitivity. By partitioning nucleic acid samples into individual reactions, dPCR enables the absolute quantification of target molecules at the single-molecule level. This partitioning approach, particularly in droplet digital PCR (ddPCR), allows for an enhanced effective concentration in minute volumes, minimizing the impact of PCR inhibitors commonly found in blood samples. The result is an increased detection sensitivity, crucial for detecting low concentrations of nucleic acids, especially in complex sample matrices such as blood.

On the other hand, Universal High-Resolution Melt (U-HRM) is a versatile technique seamlessly integrated with PCR for sequence variant scanning, genotyping, and sequence matching. It offers a rapid and cost-effective solution with single-nucleotide resolution, creating sequence-dependent melting curves. When coupled with broad-range PCR, U-HRM has demonstrated clinical feasibility in diagnosing various infectious diseases, showcasing rich melting curve profiles for species-level identification. The incorporation of a machine learning curve classification algorithm enhances specificity, achieving a 90% accuracy for pathogen identification from positive blood cultures. U-HRM’s adaptability allows for the incremental expansion of the reference database, covering a broader spectrum of pathogen strains over time.

The utility of dPCR lies in its ability to achieve absolute quantification of nucleic acids at a single-molecule level, making it particularly effective for detecting low concentrations in complex samples like blood. Conversely, U-HRM excels in providing rapid and cost-effective sequence-dependent melting curve analysis for species-level identification. Its versatility and ability to integrate with PCR make it a valuable tool in clinical and research settings.

In the context of bacteremia detection, both dPCR and U-HRM contribute to advancements in molecular diagnostics, offering enhanced sensitivity and specificity. The combined application of these technologies presents a comprehensive approach for rapid and accurate identification of pathogens, antibiotic resistance profiling, and ultimately guiding therapeutic management in cases of bloodstream infections.